Addus HomeCare Corporation (FRA:A41)
Germany · Delayed Price · Currency is EUR | Market Cap | 1.41B -22.6% |
| Revenue (ttm) | 1.26B +19.6% |
| Net Income | 86.51M +26.3% |
| EPS | 4.70 +22.7% |
| Shares Out | n/a |
| PE Ratio | 16.27 |
| Forward PE | 12.48 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 76.50 |
| Previous Close | 75.50 |
| Day's Range | 76.50 - 76.50 |
| 52-Week Range | 75.50 - 104.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 4, 2026 |
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal ... [Read more]
Financial Performance
In 2025, Addus HomeCare's revenue was $1.42 billion, an increase of 23.21% compared to the previous year's $1.15 billion. Earnings were $95.91 million, an increase of 30.32%.
Financial numbers in USD Financial StatementsNews
Addus HomeCare Transcript: RBC Capital Markets Global Healthcare Conference 2026
Regulatory changes have minimal impact on PCS growth and acquisition plans, while compliance investments strengthen payer relationships. Operational momentum continues in key states, with technology and Bridge Programs supporting census and admissions growth. M&A activity is robust, and financial outlook remains positive.
Addus HomeCare price target lowered to $92 from $102 at Barclays
Barclays lowered the firm’s price target on Addus HomeCare (ADUS) to $92 from $102 and keeps an Underweight rating on the shares. The Centers for Medicare and Medicaid Services imposed…
Addus HomeCare Transcript: Bank of America Global Healthcare Conference 2026
Sequential census and hours growth continued across major markets, aided by technology adoption and operational efficiencies. Balanced growth between rate and volume is being achieved, with recent acquisitions expanding scale and payer relationships. Regulatory and reimbursement outlooks remain stable, supporting ongoing M&A and segment growth strategies.
Addus HomeCare price target lowered to $142 from $150 at Citizens
Citizens lowered the firm’s price target on Addus HomeCare (ADUS) to $142 from $150 and keeps an Outperform rating on the shares. The firm’s outlook remains constructive, with expectations for…
Addus HomeCare to Participate in Upcoming Investor Conferences in May
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences in May: BofA Securi...
Addus HomeCare price target lowered to $140 from $147 at BofA
BofA lowered the firm’s price target on Addus HomeCare (ADUS) to $140 from $147 and keeps a Buy rating on the shares. Following the company’s Q1 report, the firm maintains…
Addus HomeCare Earnings Call Transcript: Q1 2026
Revenue grew 7.7% to $363.6M in Q1 2026, with adjusted EPS up 14.1% and strong cash flow supporting debt reduction and M&A. Personal care and hospice segments drove growth, aided by rate increases and operational improvements.
Addus HomeCare Earnings release: Q1 2026
Addus HomeCare released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
Addus HomeCare Quarterly report: Q1 2026
Addus HomeCare has published its Q1 2026 quarterly earnings report on May 5, 2026.
Addus HomeCare Slides: Q1 2026
Addus HomeCare has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 5, 2026.
Addus HomeCare reports Q1 adjusted EPS $1.62, consensus $1.54
Reports Q1 revenue $363.6M, consensus $366.34M. Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, “Addus had a solid start to 2026, delivering an improved year-over-...
Addus HomeCare sees ‘significant opportunities’ in 2026 for organic growth
“We are pleased with the favorable trends in our business and believe we have significant opportunities in 2026 for continued organic growth and for deriving additional value from acquired operations.
Addus HomeCare Announces First Quarter 2026 Financial Results
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2026. First Qua...
Addus HomeCare Proxy statement: Proxy filing
Addus HomeCare filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.
Addus HomeCare Announces First Quarter 2026 Earnings Release and Conference Call
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2026, o...
Addus HomeCare price target lowered to $102 from $112 at Barclays
Barclays lowered the firm’s price target on Addus HomeCare (ADUS) to $102 from $112 and keeps an Underweight rating on the shares. The firm revised models in the healthcare facilities…
Addus HomeCare Transcript: 2026 KeyBanc Capital Markets Healthcare Forum
Key growth drivers included hospice revitalization and targeted census expansion, with sequential census growth expected in 2026. Rate increases in major states and technology-driven hiring and fill rate improvements support operational strength. M&A focus remains on small personal care deals and select clinical opportunities.
Addus HomeCare Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Exited Q4 in strong shape, with hiring and operational improvements setting up for robust 2026 growth. Technology initiatives like the caregiver app and AI are enhancing efficiency, while regulatory and Medicaid changes are being managed through strong compliance and state relationships. M&A focus remains on Personal Care, with integration of recent acquisitions progressing smoothly.
Addus HomeCare Slides: Investor presentation
Addus HomeCare has posted slides in relation to its latest quarterly earnings report, which was published on March 11, 2026.
Addus HomeCare to Participate in Upcoming March Investor Conferences
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences: Oppenheimer 36th A...
Addus HomeCare Transcript: 47th Annual Raymond James Institutional Investor Conference
Margins have expanded to 12-13% through scale, M&A, and operational improvements, with recent acquisitions performing well. Rate increases in key states and technology adoption are supporting growth, while census is expected to rebound mid-2024. M&A and margin expansion remain top priorities.
Addus HomeCare price target lowered to $135 from $140 at Stephens
Stephens analyst Scott Fidel lowered the firm’s price target on Addus HomeCare (ADUS) to $135 from $140 and keeps an Overweight rating on the shares. The firm trimmed out-year estimates…
Addus HomeCare price target lowered to $135 from $140 at Stephens
Stephens analyst Scott Fidel lowered the firm’s price target on Addus HomeCare (ADUS) to $135 from $140 and keeps an Overweight rating on the shares. The firm trimmed out-year estimates…
Addus HomeCare to Participate in the Raymond James & Associates 47th Annual Institutional Investors Conference
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that management will participate in the Raymond James & Associates 47th Ann...
Addus HomeCare falls -12.4%
Addus HomeCare (ADUS) is down -12.4%, or -$14.62 to $103.01.